<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2025.1609815</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of finger acupressure combined with lower limb rehabilitation training machine on stroke recovery</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Liu</surname><given-names>Xiaoxue</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Zhang</surname><given-names>Feng</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/565138/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Yanhong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhao</surname><given-names>Jieqiong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Du</surname><given-names>Yatao</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Qian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Li</surname><given-names>Weifang</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3032714/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Rehabilitation Department of Hebei Province Traditional Chinese Medicine Hospital</institution>, <addr-line>Shijiazhuang</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Rehabilitation Department of the Third Hospital of Hebei Medical University</institution>, <addr-line>Shijiazhuang</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Rehabilitation Department of Hebei University of Chinese Medicine Fourth Affiliated Hospital</institution>, <addr-line>Shijiazhuang</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Rehabilitation Department of Medicine, Xingtai People&#x2019;s Hospital</institution>, <addr-line>Xingtai</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002">
<p>Edited by: Wen-Jun Tu, Capital Medical University, China</p></fn>
<fn fn-type="edited-by" id="fn0003">
<p>Reviewed by: Duy-Thai Nguyen, Ministry of Health, Vietnam</p>
<p>Jing Huang, The First Affiliated Hospital of Xinxiang Medical University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Weifang Li, <email>lwfliweifang@163.com</email></corresp>
<fn fn-type="equal" id="fn0001"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1609815</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Liu, Zhang, Li, Zhao, Du, Zhang and Li.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Liu, Zhang, Li, Zhao, Du, Zhang and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Stroke is a common acute cerebrovascular disease, and rehabilitation therapy plays a crucial role in the recovery of stroke patients.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>In this retrospective study, we first enrolled 80 stroke patients. These participants were then randomly divided into two groups: the treatment group underwent finger acupressure combined with lower limb rehabilitation training machine, and the control group received basic rehabilitation therapy. Baseline differences between the two groups were analyzed, as well as changes in motor function (FMA, sFMA, MAS, 10-Meter Walk Test, 6-Minute Walk Test), balance ability (Tinetti Test, FRT, MRT, TUGT), neural repair markers (NSE, NFL, BDNF), blood and gas exchange parameters (SpO&#x2082;, RDW, PLT), and immune and inflammatory responses (CRP, IL-6, IL-10) before and after rehabilitation. A multivariate logistic regression analysis was conducted to evaluate the impact of rehabilitation methods, stroke-related factors, and their interactions on motor function and balance recovery. Additionally, long-term quality of life and one-year recurrence rates were compared between the treatment and control groups.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>After treatment, compared with the control group, the treatment group showed significant improvements in motor function, balance ability, nerve repair, blood and gas exchange, immune and inflammatory response indicators. In addition to treatment methods, stroke type, stroke location, NIHSS score, and mRS score also significantly affect the recovery of motor function and balance ability. The treatment group has a better therapeutic effect in patients with lower baseline NIHSS scores, mRS scores, and ischemic stroke. The combination of finger acupressure and lower limb rehabilitation training machines can significantly improve the long-term quality of life of patients and reduce the one-year stroke recurrence rate.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>Finger acupressure combined with the lower limb rehabilitation training machine enhances motor function and balance recovery in stroke patients by promoting neural repair, improving immune function, and reducing inflammatory responses. This therapeutic approach is particularly effective in patients with lower baseline NIHSS and mRS scores and those with ischemic stroke.</p>
</sec>
</abstract>
<kwd-group>
<kwd>finger acupressure</kwd>
<kwd>lower limb rehabilitation training machine</kwd>
<kwd>stroke</kwd>
<kwd>motor function</kwd>
<kwd>balance ability</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="27"/>
<page-count count="11"/>
<word-count count="6932"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neurorehabilitation</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>&#x201C;Cerebral stroke&#x201D; also known as &#x201C;stroke&#x201D; or &#x201C;cerebrovascular accident (CVA),&#x201D; is an acute cerebrovascular disease (<xref ref-type="bibr" rid="ref1">1</xref>). It is a group of diseases caused by sudden rupture of cerebral blood vessels or blockage of blood vessels, leading to impaired blood flow to the brain and resulting in brain tissue damage (<xref ref-type="bibr" rid="ref2">2</xref>). Stroke is characterized by high incidence, high mortality, and high disability rates. It includes ischemic and hemorrhagic strokes, with ischemic stroke being more common, accounting for 60&#x2013;70% of all strokes (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref4">4</xref>). Internal carotid artery and vertebral artery occlusion and stenosis can lead to ischemic stroke, mostly occurring in individuals over 40&#x202F;years old, with a higher incidence in males than females (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref6">6</xref>). Severe cases may result in death. Hemorrhagic stroke has a higher mortality rate (<xref ref-type="bibr" rid="ref7">7</xref>). Studies indicate that stroke has become the leading cause of death in China and the primary cause of disability among Chinese adults (<xref ref-type="bibr" rid="ref8">8</xref>).</p>
<p>Patients with stroke experience significant declines in motor function and balance ability, which severely impact their quality of life and independence (<xref ref-type="bibr" rid="ref9 ref10 ref11">9&#x2013;11</xref>). Rehabilitation therapy plays a crucial role in the recovery process of stroke patients. Traditional stroke rehabilitation primarily includes physical therapy, occupational therapy, and speech therapy (<xref ref-type="bibr" rid="ref12">12</xref>). With the development of rehabilitation medicine, finger acupressure and lower limb rehabilitation training machine have emerged as new rehabilitation methods and have been increasingly applied in clinical practice. Lower limb rehabilitation training machine, also known as exoskeletal lower limb walking rehabilitation robots, are primarily used for rehabilitation training in patients with walking impairments due to brain, spinal cord, muscle, or skeletal diseases (<xref ref-type="bibr" rid="ref13">13</xref>). Combining this with traditional Chinese medicine finger acupressure can promote neural pathway reconstruction in stroke patients, effectively enhancing their walking ability and ultimately aiding in the recovery of motor function, enabling patients to return to their families and society as soon as possible.</p>
<p>Existing studies have shown that both acupressure and robot-assisted upper and lower limb rehabilitation contribute to the motor recovery of stroke patients finger acupressure (<xref ref-type="bibr" rid="ref14 ref15 ref16">14&#x2013;16</xref>), but few studies have combined the two methods. This study aims to analyze the effects of finger acupressure combined with a lower limb rehabilitation training machine on the recovery of motor function and balance ability in stroke patients. The findings will provide an effective rehabilitation treatment plan for improving stroke patients&#x2019; walking function. The impact of the interaction between rehabilitation therapy methods and stroke-related factors on the recovery of stroke patients was also evaluated, which was not covered in previous studies. This study offers objective evidence for rehabilitation physicians in understanding stroke walking function recovery and prognosis. It will provide objective indicators for integrating traditional Chinese medicine treatment with modern medical equipment.</p>
</sec>
<sec sec-type="materials|methods" id="sec6">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec7">
<label>2.1</label>
<title>Patient selection</title>
<p>This retrospective study included stroke patients who were hospitalized in our hospital from September 2022 to June 2023. Patients were diagnosed with stroke based on medical history, imaging examinations, and clinical manifestations, meeting the relevant clinical diagnostic criteria outlined in the &#x201C;2022 Stroke Diagnosis and Treatment Guidelines.&#x201D; The inclusion criteria are: meeting the diagnostic criteria for stroke mentioned above; Patients who require rehabilitation treatment and are willing to receive finger acupressure combined with the lower limb rehabilitation training machine. The exclusion criteria are: cases that have been treated with other treatments since the onset of the disease and those who are currently participating in other clinical trials; Having serious primary heart, nervous system, blood or other serious diseases that affect their survival; Interrupt the participant on their own; Those who have not been treated according to regulations, are unable to determine the efficacy, or have incomplete data that affects the assessment of efficacy; Patients with lower limb fractures or cognitive impairments who are unable to cooperate. Computer-generated random numbers were used to randomly select 40 patients from each group, with a total of 80 patients, to ensure that each group&#x2019;s sample was representative and to reduce bias.</p>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Treatment methods</title>
<p>The control group received basic rehabilitation treatment, including physical therapy, occupational therapy, and speech therapy. Physical therapy included exercise therapy, electrotherapy, and thermal/cold therapy. Occupational therapy included functional training, cognitive training, and psychological training. Treatment was conducted 3&#x2013;5 times per week, for 30&#x2013;45&#x202F;min per session, over 8&#x202F;weeks.</p>
<p>The treatment group received finger acupressure combined with lower limb rehabilitation training machine therapy in addition to basic rehabilitation treatment. Finger acupressure was applied to the following acupressure: Zusanli (ST36), Xuehai (SP10), Sanyinjiao (SP6), Yanglingquan (GB34), Feishu (BL13), Pishu (BL20), Shenshu (BL23), Fenglong (ST40), and Taichong (LR3). Each session lasted 20&#x202F;min, conducted continuously for 5&#x202F;days per cycle. The lower limb rehabilitation training machine was used 2&#x2013;3 times per day, for 20&#x2013;30&#x202F;min per session, 5&#x202F;days per cycle. The treatment lasted for eight cycles, with each cycle lasting 7&#x202F;days.</p>
</sec>
<sec id="sec9">
<label>2.3</label>
<title>Data collection</title>
<p>Collect baseline information of patients, including their age, gender BMI, Hypertension, diabetes, heart disease, stroke type (ischemic stroke or hemorrhagic stroke), stroke site (left hemisphere, right hemisphere or brain stem), whether to receive thrombolysis treatment, mechanical thrombectomy or surgical treatment, mRS score (mild: 0&#x2013;2, moderate: 3, severe: 4&#x2013;5), NIHSS score (mild: 1&#x2013;4, moderate: 5&#x2013;15, severe: 16&#x2013;20, very severe: 21&#x2013;24). And before and after rehabilitation treatment, FMA (Fugl Meyer Assessment), upper limb FMA (FMA-UE), lower limb FMA (FMA-LE), MAS (Modified Ashworth Scale), simplified FMA (sFMA), mRS (Modified Rankin Scale), Tinetti balance and gait assessment (Tinetti Test), modified Romberg test (MRT, assessing moderate and severe instability), Functional Reach Test (FRT), TUGT (Timed Up and Go Test), 10 meter walk test (10MWT), and 6-min walk test (6MWT). NSE (Neuron-Specific Enolase), NFL (Neurofilament light), BDNF (Brain-Derived Neurotrophic Factor), SpO&#x2082; (Peripheral Capillary Oxygen Saturation), RDW (Red Cell Distribution Width), PLT (Platelet Count), CRP (C-Reactive Protein), IL-10 (Interleukin-10), and IL-6 (Interleukin-6). Collect the occurrence of adverse events during treatment. At the completion of treatment, 1&#x202F;month after treatment, and 3&#x202F;months after treatment, quality of life scores (Stroke Specific Quality of Life, SS-QoL) were collected, as well as information on stroke recurrence within 1&#x202F;year.</p>
<p>After treatment, if the FMA score increases by &#x2265; 10 points compared to baseline, the sFMA score increases by &#x2265; 5 points, muscle tone decreases by at least 1 level, walking speed increases by &#x2265; 0.16&#x202F;m/s, walking distance increases by &#x2265; 50 meters, and four or more indicators meet the above criteria, it can be judged as improvement in motor function. Before and after treatment, the Tinetti Test score increased by &#x2265; 5 points, the FRT extension distance increased by &#x2265; 5&#x202F;cm, the MRT standing stability score increased by &#x2265; 1 level, and the TUGT completion time was shortened by &#x2265; 3&#x202F;s. If three or more indicators meet the above criteria, it can be defined as an improvement in balance ability.</p>
</sec>
<sec id="sec10">
<label>2.4</label>
<title>Data analysis</title>
<p>All analyses were performed using R 4.4.0 software. Continuous data were expressed as median (minimum-maximum) and were analyzed using independent sample t-tests or Mann&#x2013;Whitney U tests. Categorical data were presented as frequencies (percentages) and were analyzed using chi-square tests or Fisher&#x2019;s exact tests. Before conducting parametric or non-parametric tests, normality tests and homogeneity of variance tests should be performed first. If both normal distribution and homogeneity of variance are met, parametric tests should be used; otherwise, non-parametric tests should be employed. Multivariate logistic regression analysis was used to assess the effects of rehabilitation treatment methods, stroke-related factors, and their interaction on the recovery of motor function and balance ability. All statistical tests were two-tailed, with <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="sec11">
<label>3</label>
<title>Results</title>
<sec id="sec12">
<label>3.1</label>
<title>Baseline information of stroke patients</title>
<p>The cohort comprised 80 stroke patients (55% male) with median age 55&#x202F;years (range 32&#x2013;77) and BMI 28.4 (23.7&#x2013;32.7). Baseline characteristics including comorbidities (hypertension 11.3%, diabetes 8.8%, heart disease 16.3%), stroke types (ischemic 72.5%), lesion locations, and treatment modalities were well-balanced between groups (all <italic>p</italic>&#x202F;&#x003E;&#x202F;0.05, <xref ref-type="table" rid="tab1">Table 1</xref>). Functional status at enrollment showed 60% of patients had an mRS score of 0&#x2013;2, while NIHSS scores indicated 42.5% with mild stroke severity (<xref ref-type="table" rid="tab1">Table 1</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Demographic and clinical information of stroke patients.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Variables</th>
<th align="center" valign="top">All patients (<italic>n</italic> =&#x202F;80)</th>
<th align="center" valign="top">Control group (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top">Treatment group (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Age</td>
<td align="center" valign="bottom">55 (32&#x2013;77)</td>
<td align="center" valign="bottom">54 (33&#x2013;74)</td>
<td align="center" valign="bottom">56 (32&#x2013;77)</td>
<td align="center" valign="bottom">0.977</td>
</tr>
<tr>
<td align="left" valign="bottom">Gender</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.26115</td>
</tr>
<tr>
<td align="left" valign="bottom">Male</td>
<td align="center" valign="bottom">44 (55%)</td>
<td align="center" valign="bottom">25 (62.5%)</td>
<td align="center" valign="bottom">19 (47.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Female</td>
<td align="center" valign="bottom">36 (45%)</td>
<td align="center" valign="bottom">15 (37.5%)</td>
<td align="center" valign="bottom">21 (52.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">BMI</td>
<td align="center" valign="bottom">28.4 (23.7&#x2013;32.7)</td>
<td align="center" valign="bottom">28.3 (23.7&#x2013;32.7)</td>
<td align="center" valign="bottom">28.4 (24.0&#x2013;32.7)</td>
<td align="center" valign="bottom">0.855</td>
</tr>
<tr>
<td align="left" valign="bottom">Hypertension</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.15697</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">9 (11.25%)</td>
<td align="center" valign="bottom">2 (5%)</td>
<td align="center" valign="bottom">7 (17.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">71 (88.75%)</td>
<td align="center" valign="bottom">38 (95%)</td>
<td align="center" valign="bottom">33 (82.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Diabetes mellitus</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.11349</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">7 (8.75%)</td>
<td align="center" valign="bottom">6 (15%)</td>
<td align="center" valign="bottom">1 (2.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">73 (91.25%)</td>
<td align="center" valign="bottom">34 (85%)</td>
<td align="center" valign="bottom">39 (97.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Heart disease</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.22541</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">13 (16.25%)</td>
<td align="center" valign="bottom">9 (22.5%)</td>
<td align="center" valign="bottom">4 (10%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">67 (83.75%)</td>
<td align="center" valign="bottom">31 (77.5%)</td>
<td align="center" valign="bottom">36 (90%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Type of stroke</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.21059</td>
</tr>
<tr>
<td align="left" valign="bottom">Ischemic stroke</td>
<td align="center" valign="bottom">58 (72.5%)</td>
<td align="center" valign="bottom">32 (80%)</td>
<td align="center" valign="bottom">26 (65%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Hemorrhagic stroke</td>
<td align="center" valign="bottom">22 (27.5%)</td>
<td align="center" valign="bottom">8 (20%)</td>
<td align="center" valign="bottom">14 (35%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.63674</td>
</tr>
<tr>
<td align="left" valign="bottom">Left hemisphere</td>
<td align="center" valign="bottom">36 (45%)</td>
<td align="center" valign="bottom">16 (40%)</td>
<td align="center" valign="bottom">20 (50%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Right hemisphere</td>
<td align="center" valign="bottom">32 (40%)</td>
<td align="center" valign="bottom">17 (42.5%)</td>
<td align="center" valign="bottom">15 (37.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Brainstem</td>
<td align="center" valign="bottom">12 (15%)</td>
<td align="center" valign="bottom">7 (17.5%)</td>
<td align="center" valign="bottom">5 (12.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Thrombolysis</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.31049</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">10 (12.5%)</td>
<td align="center" valign="bottom">7 (17.5%)</td>
<td align="center" valign="bottom">3 (7.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">70 (87.5%)</td>
<td align="center" valign="bottom">33 (82.5%)</td>
<td align="center" valign="bottom">37 (92.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Mechanical thrombectomy</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.08567</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">15 (18.75%)</td>
<td align="center" valign="bottom">11 (27.5%)</td>
<td align="center" valign="bottom">4 (10%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">65 (81.25%)</td>
<td align="center" valign="bottom">29 (72.5%)</td>
<td align="center" valign="bottom">36 (90%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Surgery</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.47392</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">2 (2.5%)</td>
<td align="center" valign="bottom">0 (0%)</td>
<td align="center" valign="bottom">2 (5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">78 (97.5%)</td>
<td align="center" valign="bottom">40 (100%)</td>
<td align="center" valign="bottom">38 (95%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">mRS, Modified Rankin Scale</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.05167</td>
</tr>
<tr>
<td align="left" valign="bottom">Mild (0&#x2013;2)</td>
<td align="center" valign="bottom">48 (60%)</td>
<td align="center" valign="bottom">24 (60%)</td>
<td align="center" valign="bottom">24 (60%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Moderate (3)</td>
<td align="center" valign="bottom">27 (33.75%)</td>
<td align="center" valign="bottom">11 (27.5%)</td>
<td align="center" valign="bottom">16 (40%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Severe (4&#x2013;5)</td>
<td align="center" valign="bottom">5 (6.25%)</td>
<td align="center" valign="bottom">5 (12.5%)</td>
<td align="center" valign="bottom">0 (0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS, National Institutes of Health Stroke Scale</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.4045</td>
</tr>
<tr>
<td align="left" valign="bottom">Mild (1&#x2013;4)</td>
<td align="center" valign="bottom">34 (42.5%)</td>
<td align="center" valign="bottom">18 (45%)</td>
<td align="center" valign="bottom">16 (40%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Moderate (5&#x2013;15)</td>
<td align="center" valign="bottom">30 (37.5%)</td>
<td align="center" valign="bottom">16 (40%)</td>
<td align="center" valign="bottom">14 (35%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Severe (16&#x2013;20)</td>
<td align="center" valign="bottom">10 (12.5%)</td>
<td align="center" valign="bottom">5 (12.5%)</td>
<td align="center" valign="bottom">5 (12.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Very Severe (21&#x2013;24)</td>
<td align="center" valign="bottom">6 (7.5%)</td>
<td align="center" valign="bottom">1 (2.5%)</td>
<td align="center" valign="bottom">5 (12.5%)</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec13">
<label>3.2</label>
<title>Differences in motor function and balance ability indicators between the treatment and control groups before and after rehabilitation</title>
<p>Before rehabilitation treatment, there were no significant differences in motor function and balance ability indicators (such as FMA, MAS, TUGT, etc.) between the treatment and control groups. After treatment, the treatment group showed significantly higher FMA-UE, FMA-LE, sFMA, Tinetti Test, FRT, and 6MWT scores than the control group, while MAS, mRS, MRT, TUGT, and 10MWT scores were significantly lower in the treatment group compared to the control group. This indicates that the treatment group had significantly better recovery in terms of motor function, balance ability, and gait assessment (<xref ref-type="table" rid="tab2">Table 2</xref>).</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Differences in motor function and balance ability indicators between the control group and treatment group before and after rehabilitation training.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Variables</th>
<th align="center" valign="top">All patients (<italic>n</italic> =&#x202F;80)</th>
<th align="center" valign="top">Control group (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top">Treatment group (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom" colspan="5">FMA, Fugl-Meyer Assessment</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">FMA-UE</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">29 (15&#x2013;41)</td>
<td align="center" valign="bottom">28 (16&#x2013;41)</td>
<td align="center" valign="bottom">30 (15&#x2013;41)</td>
<td align="center" valign="bottom">0.744</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">44 (27&#x2013;61)</td>
<td align="center" valign="bottom">42 (27&#x2013;59)</td>
<td align="center" valign="bottom">47 (27&#x2013;61)</td>
<td align="center" valign="bottom">0.0311</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">FMA-LE</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">16 (8&#x2013;23)</td>
<td align="center" valign="bottom">16 (8&#x2013;22)</td>
<td align="center" valign="bottom">16 (8&#x2013;23)</td>
<td align="center" valign="bottom">0.765</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">21 (12&#x2013;30)</td>
<td align="center" valign="bottom">20 (12&#x2013;28)</td>
<td align="center" valign="bottom">23 (12&#x2013;30)</td>
<td align="center" valign="bottom">0.0319</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">MAS, Modified Ashworth Scale</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">2 (1&#x2013;4)</td>
<td align="center" valign="bottom">3 (1&#x2013;4)</td>
<td align="center" valign="bottom">2 (1&#x2013;4)</td>
<td align="center" valign="bottom">0.181</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">2 (0&#x2013;3)</td>
<td align="center" valign="bottom">2 (0&#x2013;3)</td>
<td align="center" valign="bottom">1 (0&#x2013;3)</td>
<td align="center" valign="bottom">0.0237</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">sFMA, Simplified Fugl-Meyer Assessment</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">19 (12&#x2013;25)</td>
<td align="center" valign="bottom">19 (12&#x2013;25)</td>
<td align="center" valign="bottom">19 (12&#x2013;24)</td>
<td align="center" valign="bottom">0.63</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">29 (19&#x2013;39)</td>
<td align="center" valign="bottom">27 (19&#x2013;39)</td>
<td align="center" valign="bottom">30 (20&#x2013;39)</td>
<td align="center" valign="bottom">0.0276</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">mRS, Modified Rankin Scale</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">2 (0&#x2013;5)</td>
<td align="center" valign="bottom">2 (0&#x2013;5)</td>
<td align="center" valign="bottom">2 (0&#x2013;5)</td>
<td align="center" valign="bottom">0.465</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">2 (0&#x2013;4)</td>
<td align="center" valign="bottom">2 (0&#x2013;4)</td>
<td align="center" valign="bottom">1 (0&#x2013;4)</td>
<td align="center" valign="bottom">0.0243</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">Tinetti Balance and Gait Assessment, Tinetti Test</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">15 (8&#x2013;21)</td>
<td align="center" valign="bottom">15 (8&#x2013;21)</td>
<td align="center" valign="bottom">15 (8&#x2013;21)</td>
<td align="center" valign="bottom">0.802</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">22 (15&#x2013;27)</td>
<td align="center" valign="bottom">20 (15&#x2013;27)</td>
<td align="center" valign="bottom">23 (15&#x2013;27)</td>
<td align="center" valign="bottom">0.0157</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">Modified Romberg Test, MRT (proportion of moderate and severe instability)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">52%</td>
<td align="center" valign="bottom">51%</td>
<td align="center" valign="bottom">53%</td>
<td align="center" valign="bottom">0.303</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">12%</td>
<td align="center" valign="bottom">14%</td>
<td align="center" valign="bottom">10%</td>
<td align="center" valign="bottom">0.0289</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">Functional Reach Test, FRT (cm)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">24 (21&#x2013;27)</td>
<td align="center" valign="bottom">24 (21&#x2013;27)</td>
<td align="center" valign="bottom">23 (21&#x2013;27)</td>
<td align="center" valign="bottom">0.392</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">33 (28&#x2013;40)</td>
<td align="center" valign="bottom">32 (28&#x2013;39)</td>
<td align="center" valign="bottom">35 (29&#x2013;40)</td>
<td align="center" valign="bottom">0.00111</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">TUGT, Timed Up and Go Test (s)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">24 (16&#x2013;33)</td>
<td align="center" valign="bottom">23 (16&#x2013;33)</td>
<td align="center" valign="bottom">25 (16&#x2013;33)</td>
<td align="center" valign="bottom">0.758</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">11 (4&#x2013;17)</td>
<td align="center" valign="bottom">14 (5&#x2013;17)</td>
<td align="center" valign="bottom">9 (4&#x2013;16)</td>
<td align="center" valign="bottom">0.000105</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">10-Meter Walk Test, 10MWT (s)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">19 (12&#x2013;26)</td>
<td align="center" valign="bottom">20 (12&#x2013;26)</td>
<td align="center" valign="bottom">19 (13&#x2013;26)</td>
<td align="center" valign="bottom">0.538</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">10 (5&#x2013;16)</td>
<td align="center" valign="bottom">12 (5&#x2013;16)</td>
<td align="center" valign="bottom">9 (5&#x2013;16)</td>
<td align="center" valign="bottom">0.0127</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">6-Minute Walk Test, 6MWT</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">174 (119&#x2013;230)</td>
<td align="center" valign="bottom">175 (121&#x2013;230)</td>
<td align="center" valign="bottom">169 (119&#x2013;230)</td>
<td align="center" valign="bottom">0.693</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">401 (256&#x2013;550)</td>
<td align="center" valign="bottom">352 (259&#x2013;537)</td>
<td align="center" valign="bottom">434 (256&#x2013;550)</td>
<td align="center" valign="bottom">0.00481</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec14">
<label>3.3</label>
<title>Differences in physiological and biochemical indicators between the treatment and control groups before and after rehabilitation</title>
<p>Before rehabilitation treatment, there were no significant differences in various neurological injury and repair-related indicators, inflammation-related indicators, and blood-related indicators between the treatment and control groups. After treatment, the treatment group showed significantly higher levels of BDNF (Brain Derived Neurotrophic Factor), SpO2 (Blood Oxygen Saturation), RDW (Red Blood Cell Distribution Width), and IL-10 (Interleukin-10) compared to the control group. In contrast, the treatment group showed significantly lower levels of PLT (Platelet Count), CRP (C-reactive Protein), and IL-6 (Interleukin-6) compared to the control group (<xref ref-type="table" rid="tab3">Table 3</xref>). This suggests that the combination of finger acupressure and lower limb rehabilitation training machine had a significant positive impact on patients&#x2019; neurorepair, immune function, and inflammatory responses.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Differences in physiological and biochemical indicators between the control group and treatment group before and after rehabilitation treatment.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Variables</th>
<th align="center" valign="top">All patients (<italic>n</italic> =&#x202F;80)</th>
<th align="center" valign="top">Control group (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top">Treatment group (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom" colspan="5">NSE, Neuron-Specific Enolase (ng/mL)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">20.38 (13.51&#x2013;26.76)</td>
<td align="center" valign="bottom">20.37 (13.79&#x2013;26.13)</td>
<td align="center" valign="bottom">20.46 (13.51&#x2013;26.76)</td>
<td align="center" valign="bottom">0.43</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">12.70 (8.37&#x2013;17.26)</td>
<td align="center" valign="bottom">13.93 (10.35&#x2013;17.26)</td>
<td align="center" valign="bottom">11.49 (8.37&#x2013;16.63)</td>
<td align="center" valign="bottom">0.000757</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">NFL, Neurofilament light (pg/mL)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">150.00 (110.31&#x2013;195.19)</td>
<td align="center" valign="bottom">155.91 (110.31&#x2013;194.49)</td>
<td align="center" valign="bottom">145.51 (120.36&#x2013;195.19)</td>
<td align="center" valign="bottom">0.637</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">66.86 (52.99&#x2013;81.45)</td>
<td align="center" valign="bottom">71.83 (57.66&#x2013;81.45)</td>
<td align="center" valign="bottom">61.95 (52.99&#x2013;78.91)</td>
<td align="center" valign="bottom">9.73E-05</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">BDNF, Brain-Derived Neurotrophic Factor</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">7.49 (4.51&#x2013;10.79)</td>
<td align="center" valign="bottom">7.49 (4.55&#x2013;10.74)</td>
<td align="center" valign="bottom">7.39 (4.51&#x2013;10.79)</td>
<td align="center" valign="bottom">0.977</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">18.95 (9.49&#x2013;31.66)</td>
<td align="center" valign="bottom">14.69 (9.49&#x2013;29.42)</td>
<td align="center" valign="bottom">24.57 (10.09&#x2013;31.66)</td>
<td align="center" valign="bottom">0.00378</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">SpO2, Oxygen Saturation (%)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">93.05 (91.12&#x2013;95.35)</td>
<td align="center" valign="bottom">92.80 (91.23&#x2013;95.34)</td>
<td align="center" valign="bottom">93.20 (91.12&#x2013;95.35)</td>
<td align="center" valign="bottom">0.686</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">97.10 (95.24&#x2013;98.79)</td>
<td align="center" valign="bottom">96.81 (95.24&#x2013;98.79)</td>
<td align="center" valign="bottom">97.64 (95.28&#x2013;98.75)</td>
<td align="center" valign="bottom">0.0304</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">Red Cell Distribution Width, RDW (%)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">18.23 (15.74&#x2013;20.00)</td>
<td align="center" valign="bottom">18.04 (16.04&#x2013;19.92)</td>
<td align="center" valign="bottom">18.46 (15.74&#x2013;20.00)</td>
<td align="center" valign="bottom">0.57</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">12.96 (11.28&#x2013;15.25)</td>
<td align="center" valign="bottom">13.70 (11.29&#x2013;15.23)</td>
<td align="center" valign="bottom">12.66 (11.28&#x2013;15.25)</td>
<td align="center" valign="bottom">0.0166</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">Platelet Count, PLT (&#x00D7; 10<sup>9</sup>/L)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">441.49 (353.29&#x2013;513.52)</td>
<td align="center" valign="bottom">446.26 (353.29&#x2013;513.52)</td>
<td align="center" valign="bottom">434.27 (353.76&#x2013;512.95)</td>
<td align="center" valign="bottom">0.744</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">280.19 (181.43&#x2013;409.24)</td>
<td align="center" valign="bottom">312.49 (208.65&#x2013;409.24)</td>
<td align="center" valign="bottom">253.44 (181.43&#x2013;404.41)</td>
<td align="center" valign="bottom">0.00244</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">CRP, C-Reactive Protein (mg/L)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">26.01 (18.55&#x2013;35.96)</td>
<td align="center" valign="bottom">26.86 (19.19&#x2013;35.54)</td>
<td align="center" valign="bottom">25.16 (18.55&#x2013;35.96)</td>
<td align="center" valign="bottom">0.465</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">7.82 (4.33&#x2013;12.31)</td>
<td align="center" valign="bottom">9.45 (4.33&#x2013;12.31)</td>
<td align="center" valign="bottom">7.12 (4.44&#x2013;11.37)</td>
<td align="center" valign="bottom">0.000286</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">IL-10, Interleukin-10 (pg/mL)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">23.65 (13.52&#x2013;31.90)</td>
<td align="center" valign="bottom">22.70 (14.06&#x2013;31.90)</td>
<td align="center" valign="bottom">25.29 (13.52&#x2013;31.90)</td>
<td align="center" valign="bottom">0.482</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">7.03 (3.62&#x2013;9.58)</td>
<td align="center" valign="bottom">6.54 (3.62&#x2013;9.53)</td>
<td align="center" valign="bottom">7.94 (4.12&#x2013;9.58)</td>
<td align="center" valign="bottom">0.00453</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="5">IL-6, Interleukin-6 (pg/mL)</td>
</tr>
<tr>
<td align="left" valign="bottom">Before rehabilitation treatment</td>
<td align="center" valign="bottom">20.29 (13.21&#x2013;28.60)</td>
<td align="center" valign="bottom">20.50 (13.21&#x2013;28.60)</td>
<td align="center" valign="bottom">20.23 (13.31&#x2013;28.29)</td>
<td align="center" valign="bottom">0.817</td>
</tr>
<tr>
<td align="left" valign="bottom">After rehabilitation treatment</td>
<td align="center" valign="bottom">5.63 (3.20&#x2013;8.58)</td>
<td align="center" valign="bottom">6.63 (3.20&#x2013;8.58)</td>
<td align="center" valign="bottom">4.91 (3.21&#x2013;8.19)</td>
<td align="center" valign="bottom">0.0026</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec15">
<label>3.4</label>
<title>Differences in adverse event rates between the treatment and control groups during treatment</title>
<p>In the treatment group, 22.5% of patients reported muscle or joint discomfort, while in the control group, 7.5% of patients reported the same. There was no significant difference between the two groups (<italic>p</italic>&#x202F;=&#x202F;0.117). In the treatment group, 22.5% of patients reported fatigue, while 12.5% in the control group reported fatigue. There was no significant difference between the two groups (<italic>p</italic>&#x202F;=&#x202F;0.377). In the treatment group, 10% of patients reported skin damage, while 5% in the control group reported the same. There was no significant difference between the two groups (<italic>p</italic>&#x202F;=&#x202F;0.671). In the control group, 12.5% of patients reported blood pressure fluctuations, while no such issues were reported in the treatment group. This was close to statistical significance (<italic>p</italic>&#x202F;=&#x202F;0.065). In the treatment group, 15% of patients reported mood swings or anxiety, while 7.5% in the control group reported the same. There was no significant difference between the two groups (<italic>p</italic>&#x202F;=&#x202F;0.479). Overall, there was no significant difference in the adverse event rates between the treatment and control groups (<xref ref-type="table" rid="tab4">Table 4</xref>).</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>The incidence of adverse events during treatment in the control group and treatment group.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Adverse events</th>
<th align="center" valign="top">All patients (<italic>n</italic> =&#x202F;80)</th>
<th align="center" valign="top">Control group (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top">Treatment group (<italic>n</italic> =&#x202F;40)</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Muscle or joint discomfort</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.1174515</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">12 (15%)</td>
<td align="center" valign="bottom">3 (7.5%)</td>
<td align="center" valign="bottom">9 (22.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">68 (85%)</td>
<td align="center" valign="bottom">37 (92.5%)</td>
<td align="center" valign="bottom">31 (77.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Fatigue</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.3773796</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">14 (17.5%)</td>
<td align="center" valign="bottom">5 (12.5%)</td>
<td align="center" valign="bottom">9 (22.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">66 (82.5%)</td>
<td align="center" valign="bottom">35 (87.5%)</td>
<td align="center" valign="bottom">31 (77.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Skin damage</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.6712184</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">6 (7.5%)</td>
<td align="center" valign="bottom">2 (5%)</td>
<td align="center" valign="bottom">4 (10%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">74 (92.5%)</td>
<td align="center" valign="bottom">38 (95%)</td>
<td align="center" valign="bottom">36 (90%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Blood pressure fluctuations</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.0646717</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">5 (6.25%)</td>
<td align="center" valign="bottom">5 (12.5%)</td>
<td align="center" valign="bottom">0 (0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">75 (93.75%)</td>
<td align="center" valign="bottom">35 (87.5%)</td>
<td align="center" valign="bottom">40 (100%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Emotional fluctuations or anxiety</td>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.4791565</td>
</tr>
<tr>
<td align="left" valign="bottom">Yes</td>
<td align="center" valign="bottom">9 (11.25%)</td>
<td align="center" valign="bottom">3 (7.5%)</td>
<td align="center" valign="bottom">6 (15%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No</td>
<td align="center" valign="bottom">71 (88.75%)</td>
<td align="center" valign="bottom">37 (92.5%)</td>
<td align="center" valign="bottom">34 (85%)</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec16">
<label>3.5</label>
<title>Multivariate logistic regression analysis of the effects of stroke-related factors and rehabilitation treatment methods on motor function recovery in stroke patients</title>
<p>The results showed that the estimated value of the treatment method was 0.340, with a <italic>p</italic> value less than 0.001, and an OR (Odds Ratio) of 1.405 (95% CI: 1.190&#x2013;1.659), indicating that the combination of finger acupressure and lower limb rehabilitation training machine significantly improved patients&#x2019; motor function. Besides rehabilitation methods, stroke-related factors also significantly influenced motor function recovery in stroke patients. The estimated value for left hemisphere stroke was 0.295, with a <italic>p</italic> value of 0.019, and an OR of 1.343 (95% CI: 1.056&#x2013;1.709), indicating that patients with left hemisphere stroke had better motor function improvement compared to those with brainstem stroke. The estimated value for right hemisphere stroke was 0.455, with a <italic>p</italic> value less than 0.001, and an OR of 1.576 (95% CI: 1.234&#x2013;2.012), indicating that patients with right hemisphere stroke showed more significant improvement in motor function compared to those with brainstem stroke. The estimated value for NIHSS score was &#x2212;0.022, with a <italic>p</italic> value of 0.003, and an OR of 0.978 (95% CI: 0.964&#x2013;0.992), suggesting that the higher the baseline NIHSS score, the lower the possibility of motor function improvement. The estimated value for mRS score was &#x2212;0.160, with a <italic>p</italic> value of 0.001, and an OR of 0.852 (95% CI: 0.778&#x2013;0.933), indicating that the higher the baseline mRS score, the lower the possibility of motor function improvement. We also conducted an interaction analysis to determine which patients benefited most from the rehabilitation treatment method. The results showed significant interactions between rehabilitation treatment methods and both NIHSS and mRS scores, with negative B values (&#x2212;0.431 and &#x2212;0.651, respectively), indicating that the combination of finger acupressure and lower limb rehabilitation training machine was less effective in patients with higher baseline NIHSS and mRS scores. However, the location of stroke had no significant effect on the intervention&#x2019;s efficacy (<xref ref-type="table" rid="tab5">Table 5</xref>).</p>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>Multivariate logistic regression analysis of stroke-related factors and rehabilitation methods on motor function in stroke patients.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Term</th>
<th align="center" valign="top">Estimate</th>
<th align="center" valign="top">std.error</th>
<th align="center" valign="top">Statistic</th>
<th align="center" valign="top"><italic>p</italic> value</th>
<th align="center" valign="top">OR</th>
<th align="center" valign="top">CI-lower</th>
<th align="center" valign="top">CI-upper</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Treatment method</td>
<td align="center" valign="bottom">0.340</td>
<td align="center" valign="bottom">0.085</td>
<td align="center" valign="bottom">4.007</td>
<td align="center" valign="bottom">0.000</td>
<td align="center" valign="bottom">1.405</td>
<td align="center" valign="bottom">1.190</td>
<td align="center" valign="bottom">1.659</td>
</tr>
<tr>
<td align="left" valign="bottom">Type of stroke (ischemic stroke)</td>
<td align="center" valign="bottom">&#x2212;0.066</td>
<td align="center" valign="bottom">0.092</td>
<td align="center" valign="bottom">&#x2212;0.711</td>
<td align="center" valign="bottom">0.479</td>
<td align="center" valign="bottom">0.936</td>
<td align="center" valign="bottom">0.781</td>
<td align="center" valign="bottom">1.122</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (left hemisphere)</td>
<td align="center" valign="bottom">0.295</td>
<td align="center" valign="bottom">0.123</td>
<td align="center" valign="bottom">2.400</td>
<td align="center" valign="bottom">0.019</td>
<td align="center" valign="bottom">1.343</td>
<td align="center" valign="bottom">1.056</td>
<td align="center" valign="bottom">1.709</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (right hemisphere)</td>
<td align="center" valign="bottom">0.455</td>
<td align="center" valign="bottom">0.125</td>
<td align="center" valign="bottom">3.645</td>
<td align="center" valign="bottom">0.000</td>
<td align="center" valign="bottom">1.576</td>
<td align="center" valign="bottom">1.234</td>
<td align="center" valign="bottom">2.012</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS</td>
<td align="center" valign="bottom">&#x2212;0.022</td>
<td align="center" valign="bottom">0.007</td>
<td align="center" valign="bottom">&#x2212;3.084</td>
<td align="center" valign="bottom">0.003</td>
<td align="center" valign="bottom">0.978</td>
<td align="center" valign="bottom">0.964</td>
<td align="center" valign="bottom">0.992</td>
</tr>
<tr>
<td align="left" valign="bottom">mRS</td>
<td align="center" valign="bottom">&#x2212;0.160</td>
<td align="center" valign="bottom">0.046</td>
<td align="center" valign="bottom">&#x2212;3.467</td>
<td align="center" valign="bottom">0.001</td>
<td align="center" valign="bottom">0.852</td>
<td align="center" valign="bottom">0.778</td>
<td align="center" valign="bottom">0.933</td>
</tr>
<tr>
<td align="left" valign="bottom">Type of stroke (ischemic stroke)</td>
<td align="center" valign="bottom">&#x2212;0.078</td>
<td align="center" valign="bottom">0.093</td>
<td align="center" valign="bottom">&#x2212;0.841</td>
<td align="center" valign="bottom">0.403</td>
<td align="center" valign="bottom">0.925</td>
<td align="center" valign="bottom">0.771</td>
<td align="center" valign="bottom">1.109</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS</td>
<td align="center" valign="bottom">&#x2212;0.022</td>
<td align="center" valign="bottom">0.007</td>
<td align="center" valign="bottom">&#x2212;3.022</td>
<td align="center" valign="bottom">0.003</td>
<td align="center" valign="bottom">0.978</td>
<td align="center" valign="bottom">0.965</td>
<td align="center" valign="bottom">0.992</td>
</tr>
<tr>
<td align="left" valign="bottom">mRS</td>
<td align="center" valign="bottom">&#x2212;0.167</td>
<td align="center" valign="bottom">0.046</td>
<td align="center" valign="bottom">&#x2212;3.602</td>
<td align="center" valign="bottom">0.001</td>
<td align="center" valign="bottom">0.846</td>
<td align="center" valign="bottom">0.772</td>
<td align="center" valign="bottom">0.926</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method</td>
<td align="center" valign="bottom">0.593</td>
<td align="center" valign="bottom">0.212</td>
<td align="center" valign="bottom">2.798</td>
<td align="center" valign="bottom">0.007</td>
<td align="center" valign="bottom">1.810</td>
<td align="center" valign="bottom">1.194</td>
<td align="center" valign="bottom">2.743</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (left hemisphere)</td>
<td align="center" valign="bottom">0.395</td>
<td align="center" valign="bottom">0.160</td>
<td align="center" valign="bottom">2.473</td>
<td align="center" valign="bottom">0.016</td>
<td align="center" valign="bottom">1.485</td>
<td align="center" valign="bottom">1.085</td>
<td align="center" valign="bottom">2.031</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (right hemisphere)</td>
<td align="center" valign="bottom">0.622</td>
<td align="center" valign="bottom">0.171</td>
<td align="center" valign="bottom">3.645</td>
<td align="center" valign="bottom">0.001</td>
<td align="center" valign="bottom">1.863</td>
<td align="center" valign="bottom">1.333</td>
<td align="center" valign="bottom">2.603</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method&#x002A;stroke location (left hemisphere)</td>
<td align="center" valign="bottom">&#x2212;0.248</td>
<td align="center" valign="bottom">0.245</td>
<td align="center" valign="bottom">&#x2212;1.010</td>
<td align="center" valign="bottom">0.316</td>
<td align="center" valign="bottom">0.781</td>
<td align="center" valign="bottom">0.483</td>
<td align="center" valign="bottom">1.262</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method&#x002A;stroke location (right hemisphere)</td>
<td align="center" valign="bottom">&#x2212;0.360</td>
<td align="center" valign="bottom">0.251</td>
<td align="center" valign="bottom">&#x2212;1.438</td>
<td align="center" valign="bottom">0.155</td>
<td align="center" valign="bottom">0.697</td>
<td align="center" valign="bottom">0.427</td>
<td align="center" valign="bottom">1.140</td>
</tr>
<tr>
<td align="left" valign="bottom">Type of stroke (ischemic stroke)</td>
<td align="center" valign="bottom">&#x2212;0.041</td>
<td align="center" valign="bottom">0.098</td>
<td align="center" valign="bottom">&#x2212;0.420</td>
<td align="center" valign="bottom">0.675</td>
<td align="center" valign="bottom">0.960</td>
<td align="center" valign="bottom">0.793</td>
<td align="center" valign="bottom">1.162</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (left hemisphere)</td>
<td align="center" valign="bottom">0.307</td>
<td align="center" valign="bottom">0.124</td>
<td align="center" valign="bottom">2.471</td>
<td align="center" valign="bottom">0.016</td>
<td align="center" valign="bottom">1.359</td>
<td align="center" valign="bottom">1.065</td>
<td align="center" valign="bottom">1.733</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (right hemisphere)</td>
<td align="center" valign="bottom">0.456</td>
<td align="center" valign="bottom">0.125</td>
<td align="center" valign="bottom">3.643</td>
<td align="center" valign="bottom">0.001</td>
<td align="center" valign="bottom">1.577</td>
<td align="center" valign="bottom">1.234</td>
<td align="center" valign="bottom">2.015</td>
</tr>
<tr>
<td align="left" valign="bottom">mRS</td>
<td align="center" valign="bottom">&#x2212;0.154</td>
<td align="center" valign="bottom">0.047</td>
<td align="center" valign="bottom">&#x2212;3.289</td>
<td align="center" valign="bottom">0.002</td>
<td align="center" valign="bottom">0.857</td>
<td align="center" valign="bottom">0.782</td>
<td align="center" valign="bottom">0.940</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method</td>
<td align="center" valign="bottom">0.201</td>
<td align="center" valign="bottom">0.196</td>
<td align="center" valign="bottom">1.026</td>
<td align="center" valign="bottom">0.308</td>
<td align="center" valign="bottom">1.223</td>
<td align="center" valign="bottom">0.833</td>
<td align="center" valign="bottom">1.796</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS</td>
<td align="center" valign="bottom">&#x2212;0.027</td>
<td align="center" valign="bottom">0.009</td>
<td align="center" valign="bottom">&#x2212;2.848</td>
<td align="center" valign="bottom">0.006</td>
<td align="center" valign="bottom">0.973</td>
<td align="center" valign="bottom">0.955</td>
<td align="center" valign="bottom">0.992</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method&#x002A;NIHSS</td>
<td align="center" valign="bottom">&#x2212;0.431</td>
<td align="center" valign="bottom">0.211</td>
<td align="center" valign="bottom">&#x2212;2.046</td>
<td align="center" valign="bottom">0.041</td>
<td align="center" valign="bottom">0.650</td>
<td align="center" valign="bottom">0.430</td>
<td align="center" valign="bottom">0.982</td>
</tr>
<tr>
<td align="left" valign="bottom">Type of stroke (ischemic stroke)</td>
<td align="center" valign="bottom">&#x2212;0.060</td>
<td align="center" valign="bottom">0.093</td>
<td align="center" valign="bottom">&#x2212;0.652</td>
<td align="center" valign="bottom">0.517</td>
<td align="center" valign="bottom">0.941</td>
<td align="center" valign="bottom">0.785</td>
<td align="center" valign="bottom">1.129</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (left hemisphere)</td>
<td align="center" valign="bottom">0.306</td>
<td align="center" valign="bottom">0.124</td>
<td align="center" valign="bottom">2.472</td>
<td align="center" valign="bottom">0.016</td>
<td align="center" valign="bottom">1.358</td>
<td align="center" valign="bottom">1.065</td>
<td align="center" valign="bottom">1.731</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (right hemisphere)</td>
<td align="center" valign="bottom">0.469</td>
<td align="center" valign="bottom">0.126</td>
<td align="center" valign="bottom">3.721</td>
<td align="center" valign="bottom">0.000</td>
<td align="center" valign="bottom">1.598</td>
<td align="center" valign="bottom">1.248</td>
<td align="center" valign="bottom">2.046</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS</td>
<td align="center" valign="bottom">&#x2212;0.022</td>
<td align="center" valign="bottom">0.007</td>
<td align="center" valign="bottom">&#x2212;3.013</td>
<td align="center" valign="bottom">0.004</td>
<td align="center" valign="bottom">0.978</td>
<td align="center" valign="bottom">0.965</td>
<td align="center" valign="bottom">0.992</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method</td>
<td align="center" valign="bottom">0.135</td>
<td align="center" valign="bottom">0.250</td>
<td align="center" valign="bottom">0.539</td>
<td align="center" valign="bottom">0.592</td>
<td align="center" valign="bottom">1.144</td>
<td align="center" valign="bottom">0.701</td>
<td align="center" valign="bottom">1.869</td>
</tr>
<tr>
<td align="left" valign="bottom">mRS</td>
<td align="center" valign="bottom">&#x2212;0.207</td>
<td align="center" valign="bottom">0.071</td>
<td align="center" valign="bottom">&#x2212;2.924</td>
<td align="center" valign="bottom">0.005</td>
<td align="center" valign="bottom">0.813</td>
<td align="center" valign="bottom">0.708</td>
<td align="center" valign="bottom">0.934</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method&#x002A;mRS</td>
<td align="center" valign="bottom">&#x2212;0.651</td>
<td align="center" valign="bottom">0.281</td>
<td align="center" valign="bottom">&#x2212;2.320</td>
<td align="center" valign="bottom">0.020</td>
<td align="center" valign="bottom">0.522</td>
<td align="center" valign="bottom">0.301</td>
<td align="center" valign="bottom">0.904</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec17">
<label>3.6</label>
<title>Multivariate logistic regression analysis of the effects of stroke-related factors and rehabilitation treatment methods on balance recovery in stroke patients</title>
<p>The results indicated that the estimated value for rehabilitation treatment was 0.387 (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001), showing that patients receiving the combination of finger acupressure and lower limb rehabilitation training machine had significantly better balance recovery than those receiving basic treatment, with an OR of 1.473 (95% CI: 1.223&#x2013;1.773). The estimated value for stroke type was 0.307 (<italic>p</italic>&#x202F;=&#x202F;0.003), suggesting that patients with ischemic stroke had better balance recovery, with an OR of 1.359 (95% CI: 1.120&#x2013;1.648). NIHSS and mRS scores were significantly negatively correlated with balance recovery, with estimated values of &#x2212;0.018 (<italic>p</italic>&#x202F;=&#x202F;0.023) and &#x2212;0.147 (<italic>p</italic>&#x202F;=&#x202F;0.008), respectively. Interaction analysis revealed a significant positive correlation between rehabilitation treatment methods and stroke type for balance recovery. That is, patients with ischemic stroke who received the combination of finger acupressure and lower limb rehabilitation training machine had better balance recovery (<xref ref-type="table" rid="tab6">Table 6</xref>).</p>
<table-wrap position="float" id="tab6">
<label>Table 6</label>
<caption>
<p>Multivariate logistic regression analysis of stroke-related factors and rehabilitation methods on balance recovery in stroke patients.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Term</th>
<th align="center" valign="top">Estimate</th>
<th align="center" valign="top">std.error</th>
<th align="center" valign="top">Statistic</th>
<th align="center" valign="top"><italic>p</italic> value</th>
<th align="center" valign="top">OR</th>
<th align="center" valign="top">CI-lower</th>
<th align="center" valign="top">CI-upper</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Treatment method</td>
<td align="center" valign="bottom">0.387</td>
<td align="center" valign="bottom">0.095</td>
<td align="center" valign="bottom">4.088</td>
<td align="center" valign="bottom">0.000</td>
<td align="center" valign="bottom">1.473</td>
<td align="center" valign="bottom">1.223</td>
<td align="center" valign="bottom">1.773</td>
</tr>
<tr>
<td align="left" valign="bottom">Type of stroke (ischemic stroke)</td>
<td align="center" valign="bottom">0.307</td>
<td align="center" valign="bottom">0.099</td>
<td align="center" valign="bottom">3.112</td>
<td align="center" valign="bottom">0.003</td>
<td align="center" valign="bottom">1.359</td>
<td align="center" valign="bottom">1.120</td>
<td align="center" valign="bottom">1.648</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (left hemisphere)</td>
<td align="center" valign="bottom">0.085</td>
<td align="center" valign="bottom">0.134</td>
<td align="center" valign="bottom">0.637</td>
<td align="center" valign="bottom">0.526</td>
<td align="center" valign="bottom">1.089</td>
<td align="center" valign="bottom">0.837</td>
<td align="center" valign="bottom">1.417</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (right hemisphere)</td>
<td align="center" valign="bottom">0.234</td>
<td align="center" valign="bottom">0.131</td>
<td align="center" valign="bottom">1.777</td>
<td align="center" valign="bottom">0.080</td>
<td align="center" valign="bottom">1.263</td>
<td align="center" valign="bottom">0.976</td>
<td align="center" valign="bottom">1.634</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS</td>
<td align="center" valign="bottom">&#x2212;0.018</td>
<td align="center" valign="bottom">0.008</td>
<td align="center" valign="bottom">&#x2212;2.326</td>
<td align="center" valign="bottom">0.023</td>
<td align="center" valign="bottom">0.982</td>
<td align="center" valign="bottom">0.967</td>
<td align="center" valign="bottom">0.997</td>
</tr>
<tr>
<td align="left" valign="bottom">mRS</td>
<td align="center" valign="bottom">&#x2212;0.147</td>
<td align="center" valign="bottom">0.053</td>
<td align="center" valign="bottom">&#x2212;2.749</td>
<td align="center" valign="bottom">0.008</td>
<td align="center" valign="bottom">0.863</td>
<td align="center" valign="bottom">0.777</td>
<td align="center" valign="bottom">0.959</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (left hemisphere)</td>
<td align="center" valign="bottom">0.080</td>
<td align="center" valign="bottom">0.134</td>
<td align="center" valign="bottom">0.601</td>
<td align="center" valign="bottom">0.550</td>
<td align="center" valign="bottom">1.084</td>
<td align="center" valign="bottom">0.834</td>
<td align="center" valign="bottom">1.408</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (right hemisphere)</td>
<td align="center" valign="bottom">0.250</td>
<td align="center" valign="bottom">0.131</td>
<td align="center" valign="bottom">1.906</td>
<td align="center" valign="bottom">0.061</td>
<td align="center" valign="bottom">1.284</td>
<td align="center" valign="bottom">0.993</td>
<td align="center" valign="bottom">1.661</td>
</tr>
<tr>
<td align="left" valign="bottom">mRS</td>
<td align="center" valign="bottom">&#x2212;0.158</td>
<td align="center" valign="bottom">0.054</td>
<td align="center" valign="bottom">&#x2212;2.938</td>
<td align="center" valign="bottom">0.004</td>
<td align="center" valign="bottom">0.854</td>
<td align="center" valign="bottom">0.768</td>
<td align="center" valign="bottom">0.949</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS</td>
<td align="center" valign="bottom">&#x2212;0.018</td>
<td align="center" valign="bottom">0.008</td>
<td align="center" valign="bottom">&#x2212;2.311</td>
<td align="center" valign="bottom">0.024</td>
<td align="center" valign="bottom">0.982</td>
<td align="center" valign="bottom">0.967</td>
<td align="center" valign="bottom">0.997</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method</td>
<td align="center" valign="bottom">0.188</td>
<td align="center" valign="bottom">0.175</td>
<td align="center" valign="bottom">1.077</td>
<td align="center" valign="bottom">0.285</td>
<td align="center" valign="bottom">1.207</td>
<td align="center" valign="bottom">0.857</td>
<td align="center" valign="bottom">1.701</td>
</tr>
<tr>
<td align="left" valign="bottom">Type of stroke (ischemic stroke)</td>
<td align="center" valign="bottom">0.162</td>
<td align="center" valign="bottom">0.145</td>
<td align="center" valign="bottom">1.114</td>
<td align="center" valign="bottom">0.269</td>
<td align="center" valign="bottom">1.176</td>
<td align="center" valign="bottom">0.884</td>
<td align="center" valign="bottom">1.563</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method&#x002A;type of stroke (ischemic stroke)</td>
<td align="center" valign="bottom">0.488</td>
<td align="center" valign="bottom">0.082</td>
<td align="center" valign="bottom">5.955</td>
<td align="center" valign="bottom">0.000</td>
<td align="center" valign="bottom">1.628</td>
<td align="center" valign="bottom">1.387</td>
<td align="center" valign="bottom">1.912</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (left hemisphere)</td>
<td align="center" valign="bottom">0.085</td>
<td align="center" valign="bottom">0.137</td>
<td align="center" valign="bottom">0.624</td>
<td align="center" valign="bottom">0.535</td>
<td align="center" valign="bottom">1.089</td>
<td align="center" valign="bottom">0.833</td>
<td align="center" valign="bottom">1.424</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (right hemisphere)</td>
<td align="center" valign="bottom">0.233</td>
<td align="center" valign="bottom">0.135</td>
<td align="center" valign="bottom">1.730</td>
<td align="center" valign="bottom">0.088</td>
<td align="center" valign="bottom">1.263</td>
<td align="center" valign="bottom">0.969</td>
<td align="center" valign="bottom">1.645</td>
</tr>
<tr>
<td align="left" valign="bottom">Type of stroke (ischemic stroke)</td>
<td align="center" valign="bottom">0.306</td>
<td align="center" valign="bottom">0.099</td>
<td align="center" valign="bottom">3.084</td>
<td align="center" valign="bottom">0.003</td>
<td align="center" valign="bottom">1.359</td>
<td align="center" valign="bottom">1.118</td>
<td align="center" valign="bottom">1.651</td>
</tr>
<tr>
<td align="left" valign="bottom">mRS</td>
<td align="center" valign="bottom">&#x2212;0.147</td>
<td align="center" valign="bottom">0.054</td>
<td align="center" valign="bottom">&#x2212;2.726</td>
<td align="center" valign="bottom">0.008</td>
<td align="center" valign="bottom">0.863</td>
<td align="center" valign="bottom">0.777</td>
<td align="center" valign="bottom">0.960</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method</td>
<td align="center" valign="bottom">0.388</td>
<td align="center" valign="bottom">0.209</td>
<td align="center" valign="bottom">1.860</td>
<td align="center" valign="bottom">0.067</td>
<td align="center" valign="bottom">1.475</td>
<td align="center" valign="bottom">0.979</td>
<td align="center" valign="bottom">2.221</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS</td>
<td align="center" valign="bottom">&#x2212;0.018</td>
<td align="center" valign="bottom">0.011</td>
<td align="center" valign="bottom">&#x2212;1.713</td>
<td align="center" valign="bottom">0.091</td>
<td align="center" valign="bottom">0.982</td>
<td align="center" valign="bottom">0.962</td>
<td align="center" valign="bottom">1.003</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method&#x002A;NIHSS</td>
<td align="center" valign="bottom">0.000</td>
<td align="center" valign="bottom">0.016</td>
<td align="center" valign="bottom">&#x2212;0.008</td>
<td align="center" valign="bottom">0.994</td>
<td align="center" valign="bottom">1.000</td>
<td align="center" valign="bottom">0.970</td>
<td align="center" valign="bottom">1.031</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (left hemisphere)</td>
<td align="center" valign="bottom">0.072</td>
<td align="center" valign="bottom">0.134</td>
<td align="center" valign="bottom">0.536</td>
<td align="center" valign="bottom">0.593</td>
<td align="center" valign="bottom">1.075</td>
<td align="center" valign="bottom">0.826</td>
<td align="center" valign="bottom">1.398</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke location (right hemisphere)</td>
<td align="center" valign="bottom">0.204</td>
<td align="center" valign="bottom">0.133</td>
<td align="center" valign="bottom">1.529</td>
<td align="center" valign="bottom">0.131</td>
<td align="center" valign="bottom">1.226</td>
<td align="center" valign="bottom">0.944</td>
<td align="center" valign="bottom">1.591</td>
</tr>
<tr>
<td align="left" valign="bottom">Type of stroke (ischemic stroke)</td>
<td align="center" valign="bottom">0.294</td>
<td align="center" valign="bottom">0.099</td>
<td align="center" valign="bottom">2.984</td>
<td align="center" valign="bottom">0.004</td>
<td align="center" valign="bottom">1.342</td>
<td align="center" valign="bottom">1.106</td>
<td align="center" valign="bottom">1.629</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS</td>
<td align="center" valign="bottom">&#x2212;0.018</td>
<td align="center" valign="bottom">0.008</td>
<td align="center" valign="bottom">&#x2212;2.304</td>
<td align="center" valign="bottom">0.024</td>
<td align="center" valign="bottom">0.982</td>
<td align="center" valign="bottom">0.967</td>
<td align="center" valign="bottom">0.997</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method</td>
<td align="center" valign="bottom">0.088</td>
<td align="center" valign="bottom">0.260</td>
<td align="center" valign="bottom">0.337</td>
<td align="center" valign="bottom">0.737</td>
<td align="center" valign="bottom">1.092</td>
<td align="center" valign="bottom">0.656</td>
<td align="center" valign="bottom">1.817</td>
</tr>
<tr>
<td align="left" valign="bottom">mRS</td>
<td align="center" valign="bottom">&#x2212;0.207</td>
<td align="center" valign="bottom">0.072</td>
<td align="center" valign="bottom">&#x2212;2.869</td>
<td align="center" valign="bottom">0.005</td>
<td align="center" valign="bottom">0.813</td>
<td align="center" valign="bottom">0.705</td>
<td align="center" valign="bottom">0.936</td>
</tr>
<tr>
<td align="left" valign="bottom">Treatment method&#x002A;mRS</td>
<td align="center" valign="bottom">0.121</td>
<td align="center" valign="bottom">0.098</td>
<td align="center" valign="bottom">1.236</td>
<td align="center" valign="bottom">0.220</td>
<td align="center" valign="bottom">1.129</td>
<td align="center" valign="bottom">0.932</td>
<td align="center" valign="bottom">1.368</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec18">
<label>3.7</label>
<title>Differences in Long-term quality of life and stroke recurrence rates within 1&#x202F;year between the treatment and control groups after rehabilitation treatment</title>
<p>The results indicated that, immediately after rehabilitation treatment, and at 1&#x202F;month and 3&#x202F;months after rehabilitation treatment, the treatment group had significantly higher quality of life scores than the control group, with the most significant difference observed at 3&#x202F;months (<xref ref-type="fig" rid="fig1">Figures 1A</xref>&#x2013;<xref ref-type="fig" rid="fig1">C</xref>). In terms of recurrence rates within 1&#x202F;year, the proportion of patients with stroke recurrence in the treatment group was significantly lower than that of patients without recurrence (14% vs. 53%) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), further demonstrating that the treatment group had a lower stroke recurrence rate.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Differences in quality of life between the control and treatment groups <bold>(A)</bold> at the completion of treatment <bold>(B)</bold> 1&#x202F;month after treatment <bold>(C)</bold> 3&#x202F;months after treatment <bold>(D)</bold> Differences in stroke recurrence rates between the control and treatment groups over the course of 1&#x202F;year (&#x002A; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, &#x002A;&#x002A; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.01, &#x002A;&#x002A;&#x002A; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001).</p>
</caption>
<graphic xlink:href="fneur-16-1609815-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Bar graphs A, B, and C show SS-QOL scores post-rehabilitation for control and treatment groups. Scores increase over time, with the treatment group consistently higher. Graph D is a stacked bar chart depicting recurrence rates, showing 14% recurrence for the treatment group and 86% for the control group. Statistical details include p-values and a chi-squared test result.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec19">
<label>4</label>
<title>Discussion</title>
<p>This study indicates that finger acupressure combined with lower limb rehabilitation training machine is closely related to the improvement of motor function and balance ability in stroke patients. Further physiological and biochemical indicators revealed that after treatment, the treatment group showed significantly higher levels of BDNF, SpO2, RDW, and IL-10 compared to the control group. However, in terms of PLT, CRP, IL-6 and other indicators, the treatment group was significantly lower than the control group. BDNF is an important neurotrophic factor that primarily functions to promote neuronal survival, enhance synaptic plasticity, and thus facilitate nerve injury recovery (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref18">18</xref>). The finger acupressure combined with the lower limb rehabilitation machine provides specific stimuli to body parts, activating reflex zones and specific pathways such as the PI3K/Akt and MAPK/ERK pathways, thus increasing the transcription and secretion of BDNF. Neurofilament light (NFL) is an important component of the neuronal cytoskeleton and belongs to the intermediate filaments family (<xref ref-type="bibr" rid="ref19">19</xref>). After stroke, ischemia or hemorrhage leads to neuronal death and axonal breakage, and neurofilament proteins are released from damaged neurons into cerebrospinal fluid and blood, thus directly reflecting the extent of neuronal damage (<xref ref-type="bibr" rid="ref20">20</xref>). Neuron-specific enolase (NSE) is a glycolytic enzyme mainly present in neurons and neuroendocrine cells. It is one of the isoenzymes of enolase and is also regarded as a biomarker of neural injury (<xref ref-type="bibr" rid="ref21">21</xref>, <xref ref-type="bibr" rid="ref22">22</xref>). Finger acupressure activates the somatosensory-motor cortex neural projection pathway by stimulating specific acupoints, promoting the release of neurotrophic substances such as brain-derived neurotrophic factor (BDNF), enhancing synaptic plasticity, and accelerating axonal regeneration, thereby repairing damaged neural connections. Meanwhile, lower limb rehabilitation training machines strengthen the &#x201C;motor-sensory feedback loop&#x201D; through repetitive motor training, promoting cortical spinal cord functional reorganization and neural pathway remodeling. This dual intervention not only significantly enhances the plasticity of the nervous system but also, more importantly, effectively reduces the extent of neuronal damage by reducing neuronal apoptosis caused by ischemia and hypoxia, thereby decreasing the levels of NFL and NSE.</p>
<p>We also found that the combination of finger acupressure and lower limb rehabilitation training machines can significantly reduce inflammation levels in patients. This may be because the specific stimulation of finger acupressure combined with lower limb rehabilitation training machines can affect the regulation of the autonomic nervous system, activate the parasympathetic nervous system, and the parasympathetic nervous system can inhibit the release of inflammatory factors (such as CRP) by regulating the vagus nerve (<xref ref-type="bibr" rid="ref23">23</xref>, <xref ref-type="bibr" rid="ref24">24</xref>). The immune function and oxygenation status (SpO2) of patients in the treatment group were significantly better than those in the control group, which may be due to the improvement of blood circulation and the increase of oxygen content in the blood through lower limb rehabilitation training machines, thereby improving oxygenation status. The patient&#x2019;s oxygenation status improves, which helps immune cells and immune factors to be delivered to the required sites faster, and the immune system is also enhanced accordingly. From the above analysis, it can be concluded that the combination of finger acupressure and lower limb rehabilitation training machine may improve the patient&#x2019;s motor function and balance ability by promoting nerve repair, enhancing immune function, and reducing inflammatory response.</p>
<p>This study also found that, in addition to rehabilitation treatment methods, stroke type, stroke location, NIHSS score, and mRS score also affect the recovery of patients&#x2019; motor function and balance ability. Patients with ischemic stroke are more likely to recover, which may be because the occurrence of ischemic stroke is usually caused by blood flow interruption due to vascular obstruction. If timely treatment is given, such as mechanical thrombectomy, the interrupted blood flow can be restored, and some damaged brain tissue can also be restored. The occurrence area of this situation is limited, and other areas of the brain can compensate for the damaged area&#x2019;s function through neural plasticity (<xref ref-type="bibr" rid="ref25">25</xref>). With the help of rehabilitation training, patients can quickly recover their motor control and coordination abilities. However, hemorrhagic stroke involves a wider range, and the hematoma formed by bleeding may compress brain tissue, leading to nerve damage, and may also be accompanied by stronger inflammatory reactions and tissue necrosis, resulting in a slower recovery rate (<xref ref-type="bibr" rid="ref26">26</xref>). The recovery speed of brainstem stroke is also slow, which may be because the brainstem is the connecting hub between the brain and the spinal cord, responsible for regulating various life activities, and the neural structure is complex. Therefore, once a stroke occurs, it will affect multiple basic life functions, making it difficult to recover (<xref ref-type="bibr" rid="ref27">27</xref>). The higher the baseline NIHSS score and mRS score, the more difficult it is for patients to recover. This may be because the higher the score, the more severe the condition, the more significant the loss of neurological function, and may also be accompanied by the occurrence of various complications.</p>
<p>Interaction analysis found that the combination of finger acupressure and lower limb rehabilitation training machine had better recovery effects in patients with lower baseline NIHSS scores, mRS scores, and ischemic stroke. This indicates that our treatment method is more suitable for patients with milder conditions, who have stronger neural plasticity, less damage to the nervous system, and stronger self-regulation ability. This discovery is of great significance in providing more personalized rehabilitation treatment plans and achieving precise treatment.</p>
<p>Long term follow-up analysis found that the quality of life and recurrence rate of the treatment group were significantly better than those of the control group, which also indicates that the combination of finger acupressure and lower limb rehabilitation training machine can not only improve patients&#x2019; motor function and balance ability in the short term, but also have a positive impact on their long-term health status, further increasing the possibility of promoting this treatment plan in clinical practice.</p>
<p>Finger acupressure combined with lower limb rehabilitation training machines may cause adverse events such as muscle and joint discomfort, fatigue, skin damage, and mood swings during clinical application. Muscle and joint discomfort often occurs during the initial stages of treatment or when the intensity is too high, manifesting as localized soreness and limited mobility. Progressive loading training (initial intensity &#x2264; 60% of maximum tolerance) combined with post-training thermotherapy or low-frequency electrical stimulation can be adopted. Fatigue accumulation is related to training intensity and patient physical condition, and can be alleviated by following the principle of intermittent training (1:1 training-rest ratio) and enhancing nutritional support. There is a certain risk of skin damage at the acupoint stimulation site, and hydrogel pads and pressure-controllable straps can be used for protection. In case of injury, antibiotics can be applied externally in a timely manner. Patients may experience emotional reactions such as anxiety due to treatment pressure or expectations of treatment effects. Emotional regulation is achieved through psychological screening before training, environmental optimization, and cognitive behavioral intervention when necessary.</p>
<p>Our study also has certain limitations. Firstly, due to the retrospective design, there may be biases in data selection, and it is difficult to control potential confounding factors. Secondly, the study did not implement blinded assessment, which may introduce measurement bias. Thirdly, the small sample size (n&#x202F;=&#x202F;80) limits the generalizability of the research results. Additionally, analysis based on non-publicly available data may be subject to selection bias. Finally, we were unable to conduct deeper mechanistic analysis, such as identifying the specific pathways through which finger acupressure combined with lower limb rehabilitation training improves patients&#x2019; motor function and balance ability. In the future, larger-scale prospective randomized controlled trials, blinded evaluation, and molecular assays (such as serum biomarker analysis, radiomics, etc.) are needed to further verify and improve the conclusions of this study.</p>
</sec>
<sec sec-type="conclusions" id="sec20">
<label>5</label>
<title>Conclusion</title>
<p>This study found that finger acupressure combined with the lower limb rehabilitation machine can significantly improve motor function and balance in stroke patients by promoting neural repair, enhancing immune function, and reducing inflammation. The treatment is particularly effective in patients with lower baseline NIHSS and mRS scores and those with ischemic stroke. It also has positive effects on the long-term health status of patients.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec21">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec22">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the Ethics Committee of Xingtai People&#x2019;s Hospital (No. HBZY2024-KY-106-01). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec sec-type="author-contributions" id="sec23">
<title>Author contributions</title>
<p>XL: Software, Writing &#x2013; original draft, Investigation, Validation, Methodology, Formal analysis, Data curation. FZ: Investigation, Methodology, Software, Writing &#x2013; original draft, Formal analysis, Data curation, Validation. YL: Writing &#x2013; original draft, Resources, Visualization, Conceptualization. JZ: Validation, Writing &#x2013; original draft, Software. YD: Data curation, Writing &#x2013; original draft, Project administration. QZ: Methodology, Writing &#x2013; original draft, Investigation. WL: Writing &#x2013; review &#x0026; editing, Supervision.</p>
</sec>
<sec sec-type="funding-information" id="sec24">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="sec25">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec26">
<title>Generative AI statement</title>
<p>The authors declare that no Gen AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="sec27">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>V</given-names></name> <name><surname>Guada</surname><given-names>L</given-names></name> <name><surname>Yavagal</surname><given-names>DR</given-names></name></person-group>. <article-title>Global epidemiology of stroke and access to acute ischemic stroke interventions</article-title>. <source>Neurology</source>. (<year>2021</year>) <volume>97</volume>:<fpage>S6</fpage>&#x2013;<lpage>s16</lpage>. doi: <pub-id pub-id-type="doi">10.1212/wnl.0000000000012781</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarikaya</surname><given-names>H</given-names></name> <name><surname>Ferro</surname><given-names>J</given-names></name> <name><surname>Arnold</surname><given-names>M</given-names></name></person-group>. <article-title>Stroke prevention--medical and lifestyle measures</article-title>. <source>Eur Neurol</source>. (<year>2015</year>) <volume>73</volume>:<fpage>150</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000367652</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feske</surname><given-names>SK</given-names></name></person-group>. <article-title>Ischemic stroke</article-title>. <source>Am J Med</source>. (<year>2021</year>) <volume>134</volume>:<fpage>1457</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.amjmed.2021.07.027</pub-id>, PMID: <pub-id pub-id-type="pmid">34454905</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herpich</surname><given-names>F</given-names></name> <name><surname>Rincon</surname><given-names>F</given-names></name></person-group>. <article-title>Management of acute ischemic stroke</article-title>. <source>Crit Care Med</source>. (<year>2020</year>) <volume>48</volume>:<fpage>1654</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ccm.0000000000004597</pub-id>, PMID: <pub-id pub-id-type="pmid">32947473</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name> <name><surname>Ni</surname><given-names>L</given-names></name> <name><surname>Wang</surname><given-names>C</given-names></name> <name><surname>Shi</surname><given-names>P</given-names></name> <name><surname>Yin</surname><given-names>L</given-names></name> <name><surname>Fu</surname><given-names>XY</given-names></name> <etal/></person-group>. <article-title>Association between internal carotid artery kinking and ischemic stroke: a population-based cross-sectional study</article-title>. <source>J Stroke Cerebrovasc Dis</source>. (<year>2023</year>) <volume>32</volume>:<fpage>107417</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2023.107417</pub-id>, PMID: <pub-id pub-id-type="pmid">37924779</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keser</surname><given-names>Z</given-names></name> <name><surname>Chiang</surname><given-names>CC</given-names></name> <name><surname>Benson</surname><given-names>JC</given-names></name> <name><surname>Pezzini</surname><given-names>A</given-names></name> <name><surname>Lanzino</surname><given-names>G</given-names></name></person-group>. <article-title>Cervical artery dissections: etiopathogenesis and management</article-title>. <source>Vasc Health Risk Manag</source>. (<year>2022</year>) <volume>18</volume>:<fpage>685</fpage>&#x2013;<lpage>700</lpage>. doi: <pub-id pub-id-type="doi">10.2147/vhrm.S362844</pub-id>, PMID: <pub-id pub-id-type="pmid">36082197</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El Husseini</surname><given-names>N</given-names></name> <name><surname>Katzan</surname><given-names>IL</given-names></name> <name><surname>Rost</surname><given-names>NS</given-names></name> <name><surname>Blake</surname><given-names>ML</given-names></name> <name><surname>Byun</surname><given-names>E</given-names></name> <name><surname>Pendlebury</surname><given-names>ST</given-names></name> <etal/></person-group>. <article-title>Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association</article-title>. <source>Stroke</source>. (<year>2023</year>) <volume>54</volume>:<fpage>e272</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1161/str.0000000000000430</pub-id>, PMID: <pub-id pub-id-type="pmid">37125534</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>HQ</given-names></name> <name><surname>Yang</surname><given-names>X</given-names></name> <name><surname>Wang</surname><given-names>CJ</given-names></name> <name><surname>Zhao</surname><given-names>XQ</given-names></name> <name><surname>Wang</surname><given-names>YL</given-names></name> <name><surname>Liu</surname><given-names>LP</given-names></name> <etal/></person-group>. <article-title>Clinical characteristics, management, and in-hospital outcomes in patients with stroke or transient ischemic attack in China</article-title>. <source>JAMA Netw Open</source>. (<year>2021</year>) <volume>4</volume>:<fpage>e2120745</fpage>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.20745</pub-id>, PMID: <pub-id pub-id-type="pmid">34387677</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Einstad</surname><given-names>MS</given-names></name> <name><surname>Saltvedt</surname><given-names>I</given-names></name> <name><surname>Lydersen</surname><given-names>S</given-names></name> <name><surname>Ursin</surname><given-names>MH</given-names></name> <name><surname>Munthe-Kaas</surname><given-names>R</given-names></name> <name><surname>Ihle-Hansen</surname><given-names>H</given-names></name> <etal/></person-group>. <article-title>Associations between post-stroke motor and cognitive function: a cross-sectional study</article-title>. <source>BMC Geriatr</source>. (<year>2021</year>) <volume>21</volume>:<fpage>103</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-021-02055-7</pub-id>, PMID: <pub-id pub-id-type="pmid">33546620</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JA</given-names></name></person-group>. <article-title>Recovery of motor function after stroke</article-title>. <source>Prog Brain Res</source>. (<year>2006</year>) <volume>157</volume>:<fpage>223</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0079-6123(06)57015-3</pub-id>, PMID: <pub-id pub-id-type="pmid">17046674</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rahayu</surname><given-names>UB</given-names></name> <name><surname>Wibowo</surname><given-names>S</given-names></name> <name><surname>Setyopranoto</surname><given-names>I</given-names></name> <name><surname>Hibatullah</surname><given-names>RM</given-names></name></person-group>. <article-title>Effectiveness of physiotherapy interventions in brain plasticity, balance and functional ability in stroke survivors: a randomized controlled trial</article-title>. <source>NeuroRehabilitation</source>. (<year>2020</year>) <volume>47</volume>:<fpage>463</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.3233/nre-203210</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winstein</surname><given-names>CJ</given-names></name> <name><surname>Stein</surname><given-names>J</given-names></name> <name><surname>Arena</surname><given-names>R</given-names></name> <name><surname>Bates</surname><given-names>B</given-names></name> <name><surname>Cherney</surname><given-names>LR</given-names></name> <name><surname>Cramer</surname><given-names>SC</given-names></name> <etal/></person-group>. <article-title>Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association</article-title>. <source>Stroke</source>. (<year>2016</year>) <volume>47</volume>:<fpage>e98</fpage>&#x2013;<lpage>e169</lpage>. doi: <pub-id pub-id-type="doi">10.1161/str.0000000000000098</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name> <name><surname>Fan</surname><given-names>T</given-names></name> <name><surname>Qi</surname><given-names>Q</given-names></name> <name><surname>Wang</surname><given-names>J</given-names></name> <name><surname>Qiu</surname><given-names>H</given-names></name> <name><surname>Zhang</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>Efficacy of a novel exoskeletal robot for locomotor rehabilitation in stroke patients: a multi-center, non-inferiority, randomized controlled trial</article-title>. <source>Front Aging Neurosci</source>. (<year>2021</year>) <volume>13</volume>:<fpage>706569</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnagi.2021.706569</pub-id>, PMID: <pub-id pub-id-type="pmid">34497506</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>HS</given-names></name> <name><surname>Sok</surname><given-names>SR</given-names></name> <name><surname>Kang</surname><given-names>JS</given-names></name></person-group>. <article-title>Effects of Meridian acupressure for stroke patients in Korea</article-title>. <source>J Clin Nurs</source>. (<year>2009</year>) <volume>18</volume>:<fpage>2145</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2702.2008.02522.x</pub-id>, PMID: <pub-id pub-id-type="pmid">19583646</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takebayashi</surname><given-names>T</given-names></name> <name><surname>Takahashi</surname><given-names>K</given-names></name> <name><surname>Amano</surname><given-names>S</given-names></name> <name><surname>Gosho</surname><given-names>M</given-names></name> <name><surname>Sakai</surname><given-names>M</given-names></name> <name><surname>Hashimoto</surname><given-names>K</given-names></name> <etal/></person-group>. <article-title>Robot-assisted training as self-training for upper-limb hemiplegia in chronic stroke: a randomized controlled trial</article-title>. <source>Stroke</source>. (<year>2022</year>) <volume>53</volume>:<fpage>2182</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1161/strokeaha.121.037260</pub-id>, PMID: <pub-id pub-id-type="pmid">35345897</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>H</given-names></name> <name><surname>Bosomworth</surname><given-names>H</given-names></name> <name><surname>Krebs</surname><given-names>HI</given-names></name> <name><surname>Van Wijck</surname><given-names>F</given-names></name> <name><surname>Howel</surname><given-names>D</given-names></name> <name><surname>Wilson</surname><given-names>N</given-names></name> <etal/></person-group>. <article-title>Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial</article-title>. <source>Lancet</source>. (<year>2019</year>) <volume>394</volume>:<fpage>51</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0140-6736(19)31055-4</pub-id>, PMID: <pub-id pub-id-type="pmid">31128926</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>V</given-names></name> <name><surname>Singh</surname><given-names>TG</given-names></name> <name><surname>Kaur</surname><given-names>A</given-names></name> <name><surname>Mannan</surname><given-names>A</given-names></name> <name><surname>Dhiman</surname><given-names>S</given-names></name></person-group>. <article-title>Brain-derived neurotrophic factor: a novel dynamically regulated therapeutic modulator in neurological disorders</article-title>. <source>Neurochem Res</source>. (<year>2023</year>) <volume>48</volume>:<fpage>317</fpage>&#x2013;<lpage>39</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11064-022-03755-1</pub-id>, PMID: <pub-id pub-id-type="pmid">36308619</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lima Giacobbo</surname><given-names>B</given-names></name> <name><surname>Doorduin</surname><given-names>J</given-names></name> <name><surname>Klein</surname><given-names>HC</given-names></name> <name><surname>Dierckx</surname><given-names>R</given-names></name> <name><surname>Bromberg</surname><given-names>E</given-names></name> <name><surname>De Vries</surname><given-names>EFJ</given-names></name></person-group>. <article-title>Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation</article-title>. <source>Mol Neurobiol</source>. (<year>2019</year>) <volume>56</volume>:<fpage>3295</fpage>&#x2013;<lpage>312</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12035-018-1283-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30117106</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>A</given-names></name> <name><surname>Rao</surname><given-names>MV</given-names></name> <name><surname>Nixon</surname><given-names>RA</given-names></name></person-group>. <article-title>Neurofilaments and neurofilament proteins in health and disease</article-title>. <source>Cold Spring Harb Perspect Biol</source>. (<year>2017</year>) <volume>9</volume>:<fpage>a018309</fpage>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a018309</pub-id>, PMID: <pub-id pub-id-type="pmid">28373358</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name> <name><surname>Wang</surname><given-names>H</given-names></name> <name><surname>Li</surname><given-names>L</given-names></name> <name><surname>Deng</surname><given-names>X</given-names></name> <name><surname>Bo</surname><given-names>L</given-names></name></person-group>. <article-title>Neurofilament light chain: a candidate biomarker of perioperative stroke</article-title>. <source>Front Aging Neurosci</source>. (<year>2022</year>) <volume>14</volume>:<fpage>14. 921809</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnagi.2022.921809</pub-id>, PMID: <pub-id pub-id-type="pmid">35875791</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isgr&#x00F2;</surname><given-names>MA</given-names></name> <name><surname>Bottoni</surname><given-names>P</given-names></name> <name><surname>Scatena</surname><given-names>R</given-names></name></person-group>. <article-title>Neuron-specific enolase as a biomarker: biochemical and clinical aspects</article-title>. <source>Adv Exp Med Biol</source>. (<year>2015</year>) <volume>867</volume>:<fpage>125</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-94-017-7215-0_9</pub-id>, PMID: <pub-id pub-id-type="pmid">26530364</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mochetti</surname><given-names>MM</given-names></name> <name><surname>Silva</surname><given-names>EGP</given-names></name> <name><surname>Correa</surname><given-names>AAF</given-names></name> <name><surname>Cabette</surname><given-names>MR</given-names></name> <name><surname>Perissinotti</surname><given-names>IN</given-names></name> <name><surname>E Silva</surname><given-names>LOJ</given-names></name> <etal/></person-group>. <article-title>Neuron-specific enolase at admission as a predictor for stroke volume, severity and outcome in ischemic stroke patients: a prognostic biomarker review</article-title>. <source>Sci Rep</source>. (<year>2024</year>) <volume>14</volume>:<fpage>2688</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-024-53080-6</pub-id>, PMID: <pub-id pub-id-type="pmid">38302568</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellocchi</surname><given-names>C</given-names></name> <name><surname>Carandina</surname><given-names>A</given-names></name> <name><surname>Montinaro</surname><given-names>B</given-names></name> <name><surname>Targetti</surname><given-names>E</given-names></name> <name><surname>Furlan</surname><given-names>L</given-names></name> <name><surname>Rodrigues</surname><given-names>GD</given-names></name> <etal/></person-group>. <article-title>The interplay between autonomic nervous system and inflammation across systemic autoimmune diseases</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<fpage>5</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms23052449</pub-id>, PMID: <pub-id pub-id-type="pmid">35269591</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name> <name><surname>Huang</surname><given-names>L</given-names></name> <name><surname>Le</surname><given-names>A</given-names></name> <name><surname>Wang</surname><given-names>TJ</given-names></name> <name><surname>Zhang</surname><given-names>J</given-names></name> <name><surname>Chen</surname><given-names>X</given-names></name> <etal/></person-group>. <article-title>Interactions between the autonomic nervous system and the immune system after stroke</article-title>. <source>Compr Physiol</source>. (<year>2022</year>) <volume>12</volume>:<fpage>3665</fpage>&#x2013;<lpage>704</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cphy.c210047</pub-id>, PMID: <pub-id pub-id-type="pmid">35766834</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>Y</given-names></name> <name><surname>Bai</surname><given-names>Y</given-names></name></person-group>. <article-title>A review of exercise-induced neuroplasticity in ischemic stroke: pathology and mechanisms</article-title>. <source>Mol Neurobiol</source>. (<year>2020</year>) <volume>57</volume>:<fpage>4218</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12035-020-02021-1</pub-id>, PMID: <pub-id pub-id-type="pmid">32691303</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohashi</surname><given-names>SN</given-names></name> <name><surname>Delong</surname><given-names>JH</given-names></name> <name><surname>Kozberg</surname><given-names>MG</given-names></name> <name><surname>Mazur-Hart</surname><given-names>DJ</given-names></name> <name><surname>Van Veluw</surname><given-names>SJ</given-names></name> <name><surname>Alkayed</surname><given-names>NJ</given-names></name> <etal/></person-group>. <article-title>Role of inflammatory processes in hemorrhagic stroke</article-title>. <source>Stroke</source>. (<year>2023</year>) <volume>54</volume>:<fpage>605</fpage>&#x2013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1161/strokeaha.122.037155</pub-id>, PMID: <pub-id pub-id-type="pmid">36601948</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname><given-names>KM</given-names></name> <name><surname>Tuhrim</surname><given-names>S</given-names></name> <name><surname>Naidich</surname><given-names>TP</given-names></name></person-group>. <article-title>Brainstem vascular stroke anatomy</article-title>. <source>Neuroimaging Clin N Am</source>. (<year>2005</year>) <volume>15</volume>:<fpage>297</fpage>&#x2013;<lpage>324</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nic.2005.05.005</pub-id></citation></ref>
</ref-list>
</back>
</article>